Latest filing published 03 Aug 2026 for Altimmune, Inc., €1,834. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
M. Scot Roberts is a declared insider of Altimmune, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 31 July 2021 and 31 July 2026, the trades on record add up to 23 filings.
No open-market purchase appears, only 1 sale worth €424k. The rest of the record consists of 10 share grants and 12 option exercises.
The newest entry dates from 3 August 2026: a share grant of €1,834, in Altimmune, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations